Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Yap

Showing results (1-10 of 260) with videos related to

Pageof 26
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 22, 2025
The development of ATR inhibitorsTimothy A Yap
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2016
Targeting MET Exon 14 Skipping Alterations: Has Lung Cancer MET Its Match?Timothy A Yap, Sanjay Popat
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2013
The role of afatinib in the management of non-small cell lung carcinomaTimothy A Yap, Sanjay Popat
The Oncologist|October 18, 2017
Development of Molecularly Driven Targeted Combination StrategiesTimothy A Yap, Jordi Rodon
Annual Review of Pharmacology and Toxicology|January 13, 2012
Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeuticsTimothy A Yap, Paul Workman
Pharmacogenomics and Personalized Medicine|October 4, 2014
Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancerTimothy A Yap, Sanjay Popat
Current Problems in Cancer|April 5, 2017
Precision medicine in oncologyNaoko Takebe, Timothy A Yap
Cancer Journal (Sudbury, Mass.)|December 14, 2021
The Principles and Practice of PARP Inhibitor TherapyTimothy A Yap, Robert L Coleman
Clinical Genitourinary Cancer|October 10, 2006
Adjuvant therapy of renal cell carcinomaTimothy A Yap, Tim G Eisen
Clinical and Translational Medicine|July 17, 2025
Unlocking the therapeutic potential of ATR inhibitors: Advances, challenges, and opportunities in cancer therapyTejaswini P Reddy, Timothy A Yap
Pageof 26

Showing results (1-10 of 260) with videos related to

Sort By:
Pageof 26
Clinical Advances in Hematology & Oncology : H&O|April 22, 2025
The development of ATR inhibitorsTimothy A Yap
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2016
Targeting MET Exon 14 Skipping Alterations: Has Lung Cancer MET Its Match?Timothy A Yap, Sanjay Popat
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2013
The role of afatinib in the management of non-small cell lung carcinomaTimothy A Yap, Sanjay Popat
The Oncologist|October 18, 2017
Development of Molecularly Driven Targeted Combination StrategiesTimothy A Yap, Jordi Rodon
Annual Review of Pharmacology and Toxicology|January 13, 2012
Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeuticsTimothy A Yap, Paul Workman
Pharmacogenomics and Personalized Medicine|October 4, 2014
Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancerTimothy A Yap, Sanjay Popat
Current Problems in Cancer|April 5, 2017
Precision medicine in oncologyNaoko Takebe, Timothy A Yap
Cancer Journal (Sudbury, Mass.)|December 14, 2021
The Principles and Practice of PARP Inhibitor TherapyTimothy A Yap, Robert L Coleman
Clinical Genitourinary Cancer|October 10, 2006
Adjuvant therapy of renal cell carcinomaTimothy A Yap, Tim G Eisen
Clinical and Translational Medicine|July 17, 2025
Unlocking the therapeutic potential of ATR inhibitors: Advances, challenges, and opportunities in cancer therapyTejaswini P Reddy, Timothy A Yap
Pageof 26